)-dependent secretion (CDS) via Ca 2+ influx through voltage-gated Ca 2+ channels. We report a new type of somatic exocytosis triggered by the action potential per se-Ca 2+ -independent but voltage-dependent secretion (CiVDS)-in dorsal root ganglion neurons. Here we uncovered the molecular mechanism of CiVDS, comprising a voltage sensor, fusion machinery, and their linker. Specifically, the voltage-gated N-type Ca 2+ channel (Ca V 2.2) is the voltage sensor triggering CiVDS, the SNARE complex functions as the vesicle fusion machinery, the ''synprint'' of Ca V 2.2 serves as a linker between the voltage sensor and the fusion machinery, and ATP is a cargo of CiVDS vesicles. Thus, CiVDS releases ATP from the soma while CDS releases glutamate from presynaptic terminals, establishing the Ca V 2.2-SNARE ''voltage-gating fusion pore'' as a novel pathway co-existing with the canonical ''Ca 2+ -gating fusion pore'' pathway for neurotransmitter release following action potentials in primary sensory neurons.
INTRODUCTION
It is generally assumed that membrane depolarization-evoked vesicular release is a intracellular free Ca 2+ concentration (Ca 2+ )-dependent process in nerve terminals (Katz and Miledi, 1967; Meinrenken et al., 2003) , neuronal somata (Huang and Neher, 1996) , and neuroendocrine cells (Grodsky and Bennett, 1966; Rubin, 1970) . Action potentials (APs) mediate Ca 2+ influx through voltage-gated Ca 2+ channels and then trigger Ca 2+ -dependent secretion (CDS). This well-established CDS theory has been extended by our previous finding of a new type of AP-mediated secretion, Ca
2+
-independent but voltage-dependent secretion (CiVDS) in primary sensory dorsal root ganglion (DRG) neurons (Zhang et al., 2004; Zhang and Zhou, 2002) .
Compared with CDS, CiVDS has revealed a new function of the AP per se to trigger exocytosis, in addition to the primary function of opening voltage-gated Ca 2+ channels to gate Ca 2+ influx. Regarding the molecular mechanism, the AP-mediated CDS has been extensively investigated over the last 30 years. Synaptotagmins function as the primary Ca 2+ sensors for evoked vesicular release (Chapman, 2002; S€ udhof, 2012) through interacting with the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex (a fourhelix complex formed by synaptobrevin, SNAP-25, and syntaxin) and phospholipids (Bennett et al., 1992; Chapman et al., 1995; Chapman and Jahn, 1994; Davletov and S€ udhof, 1993) . In contrast, the molecular mechanism underlying CiVDS remains unknown. Both CDS and CiVDS occur in primary sensory DRG neurons (Liu et al., 2011; Zhang and Zhou, 2002) . CiVDS dominates during tonic firing (< 4 Hz) at rest, whereas CDS becomes dominant during burst firing (> 20 Hz), corresponding to pain sensation, implying that CiVDS and CDS play complementary roles under physiological and pathological conditions (Zheng et al., 2009) . CDS releases both classic neurotransmitters (ATP and glutamate) and neuropeptides (calcitonin gene-related peptide and substance P) from DRG neurons to transmit innocuous or noxious sensory information (Hingtgen and Vasko, 1994; Huang and Neher, 1996; Zhang et al., 2007a) , but little is known about the cargo of CiVDS. Because only CiVDS (but not CDS) conducts exocytosis at rest (spontaneous APs at 1-4 Hz), CiVDS transmitter(s) may affect sensory homeostasis. Thus, we set out to explore the molecular mechanism and native transmitter(s) of CiVDS.
RESULTS
The N-Type Ca 2+ Channel Is Essential for CiVDS Regarding the mechanism, a CiVDS model would contain at least 3 components: a voltage sensor, fusion machinery, and a linker of the voltage sensor and fusion machinery. Whole-cell membrane capacitance (Cm) measurement during whole-cell recording in the absence of internal and external Ca 2+ has
shown that CiVDS exocytosis is readily triggered by a brief depolarization ( Figure 1A ; Zhang and Zhou, 2002) , so one or more voltage-sensing proteins on the plasma membrane must be involved to directly initiate CiVDS. We first screened for proteins containing the voltage-sensing motif S4 in the UniProt database and found $390 voltage-sensing proteins in mammals (Mus musculus, Rattus norvegicus, and Homo sapiens), all of which are voltage-gated channels. Therefore, we pharmacologically screened the voltage-gated channels (including Na + , K + , and Ca purposes, we applied available antagonists of voltage-gated channels: tetrodotoxin (TTX, 1 mM) for Na + channels, tetraethylammonium (TEA) (10 mM) for K + channels, and u-conotoxin GVIA (GVIA) (1 mM) for N-type Ca 2+ channel Ca V 2.2, the most abundant voltage-gated Ca 2+ channels in DRG neurons (Mintz et al., 1992) . Intriguingly, the Cm jump was insensitive to TTX and TEA (Figures 1B; Figures S1 and S2) but notably reduced by GVIA ( Figures 1A and 1B) , which not only occludes the open pore but also blocks the gating charge of Cav2.2 Elmslie, 2009, 2010) , implying the functional involvement of Ca V 2.2 channels in CiVDS.
To further investigate the role of Ca V 2.2 in CiVDS, we planned to use a short hairpin RNA (shRNA)-based knockdown (KD) approach, which required culturing DRG neurons for at least 3 days. To our surprise, CiVDS spontaneously decreased with culture time and had nearly disappeared after 3 days of culture ( Figure 1C ), whereas CDS increased (Figures S3A and S3B) . Consistent with its involvement in CiVDS, both the expression level and the functional current of Ca V 2.2 decreased markedly after 3 days of culture (Figures 1D and 1E) . Although this ''spontaneous KD'' precluded KD experiments in cultured DRG neurons, we were able to test whether CiVDS is rescued by overexpression (OE) of Ca V 2.2 after culture for 3 days. As expected, Ca V 2.2 OE fully restored CiVDS ( Figures 1F and 1G ) without affecting CDS ( Figure S4 ), indicating a critical role of Ca V 2.2 channels in CiVDS.
To further determine the role of endogenous Ca V 2.2 in CiVDS, we performed in vivo KD by surgically injecting shRNA-expressing adeno-associated viruses (AAVs) into the L5 DRG ( Figure 2B ). Two independent shRNAs were designed to target Ca V 2.2, whereas a non-targeting scrambled shRNA served as a control.
Western blot and immunofluorescence showed efficient KD of Ca V 2.2 both in vitro and in vivo with the two shRNAs ( Figures  2A and 2C ) but not the scrambled shRNA (data not shown). In addition, real-time PCR showed that both shRNAs specifically targeted Ca V 2.2 but not other subtypes of voltage-gated Ca 2+ channels in DRG neurons ( Figure S5A) . Strikingly, Cm recordings demonstrated a dramatic decrease ($70%) of CiVDS in Ca V 2.2 KD versus control neurons ( Figures 2D and 2E) . Together, all of these findings demonstrate that Ca V 2.2 channels are essential for CiVDS.
The Voltage-Sensing Motif, but Not the Pore Region of Ca V 2.2, Is Critical for CiVDS To further characterize the voltage-sensing properties of Ca V 2.2 in triggering CiVDS, we generated loss-of-function mutations of Ca V 2.2 at its voltage-sensitive or pore filter regions (Catterall, 2010; Yang et al., 1993) . To generate voltage-insensitive Ca V 2.2, the conserved voltage-sensing and positively charged S4 motif in domain III was neutralized by substituting the second and third arginines (R1256 and R1259) with glutamines (S4 mutation; Figure 3A ). As expected, the S4 mutant showed a dramatic reduction in the voltage-triggered Ca 2+ current ( Figure 3B ). Cell surface biotinylation assays revealed similar expression of the S4 mutant and the wild-type (WT) Ca V 2.2 both for the total and plasma membrane ( Figure 3C ). Remarkably, unlike WT Ca V 2.2, the S4 mutation failed to rescue CiVDS after 3 days in culture (Figures 3D and 3E) . Similarly, CDS was also reduced greatly in neurons expressing the S4 mutation ( Figures S6A and S6B) , probably caused by the reduced Ca 2+ currents ( Figure S6B ).
Next we examined whether a mutation at the pore region affects CiVDS. Glutamic acids (E314 and E664) located in the pore filter regions in domains I and II were mutated to glutamines to generate a pore region mutation ( Figure 4A ). Consistent with previous studies (Yang et al., 1993) , this mutation had no effect on membrane current but blocked the Ca 2+ influx, as revealed by combining patch-clamp and [Ca 2+ ] i measurements in HEK293A cells expressing WT Ca V 2.2 or the pore mutation ( Figures 4B  and 4C ). Interestingly, the pore region mutant retained a rescue effect on CiVDS similar to WT Ca V 2.2 but dramatically blocked CDS (Figures 4D-4F ; Figures S6C and S6D ). These findings demonstrate that, upon membrane depolarization, the Ca V 2.2 channel triggers CiVDS in DRG neurons, and this is largely dependent on its voltage-sensing function but not the pore Ca 2+ permeability. SNAP-25, and syntaxin 1) has long been considered an essential component of vesicle secretion (Hanson et al., 1997; Poirier et al., 1998; Sutton et al., 1998) . We proposed that Ca V 2.2 triggers CiVDS through binding to the SNARE complex. To test this hypothesis, we first performed co-immunoprecipitation (coIP) in native DRG tissues and found a physical interaction of Ca V 2.2 with SNAP-25 in DRG neurons ( Figure 5A ). Similar results were also obtained in vitro by overexpressing FLAG-Ca V 2.2 and SNAP-25 in HEK293A cells ( Figure 5B ). Second, immunofluorescence showed co-localization of Ca V 2.2 with SNAP-25 on the plasma membrane of DRG neurons ( Figure 5C ). Third, OE of SNAP-25 was able to rescue CiVDS in DRG neurons cultured for 3 days (Figures 5D and 5E) . Fourth, we expressed tetanus toxin and botulinum toxin C in DRG neurons to cleave the SNARE complex (Blasi et al., 1993; Link et al., 1992; Schiavo et al., 1992) . DRG neurons expressing the combined toxins showed a significant reduction in CDS and fluorescence intensity of SNAP-25 and VAMP-2 24 hr after transfection ( Figure S7 ), indicating efficient cleavage of the SNARE complex. Concurrently, the combined toxins blocked $50% of CiVDS in DRG neurons (Figures 5F and 5G) . Together, these results demonstrate that CiVDS is SNAREdependent and that the Ca V 2.2 channel can co-operate with the SNARE complex to mediate CiVDS in DRG neurons.
The ''Synprint'' Linker of Ca V 2.2-SNARE Is Essential for CiVDS Because we had shown that Ca V 2.2 binds the SNARE complex both in vitro and in vivo, we next investigated whether this binding is responsible for CiVDS in DRG neurons. Previous studies by Catterall (1999) have shown that the synprint region of Ca V 2.2, amino acids 773-859 in the intracellular loop between domains II and III, is essential for the binding between Ca V 2.2 and the SNARE complex (Sheng et al., 1994) . Thus, we constructed synprint-truncated Ca V 2.2 and found that this truncation did not change the evoked Ca 2+ current, as evidenced by recordings in HEK293A cells ( Figures S8D and S8E ), consistent with a previous report (Harkins et al., 2004) . To determine whether Ca V 2.2-and SNARE-dependent CiVDS requires the synprint, first, coIP showed that synprint-truncated Ca V 2.2 (Dsynprint) lost the ability to bind the SNARE complex ( Figures 6B and 6C ), indicating that the synprint region is the binding site between Ca V 2.2 and the SNARE complex. Second, to determine the function of this binding in CiVDS, a synprint peptide was synthesized and dialyzed into freshly isolated DRG neurons to disrupt the binding between Ca V 2.2 and the SNARE complex (Mochida et al., 1996; Rettig et al., 1997) . Strikingly, the synprint peptide substantially inhibited CiVDS by >60%, whereas the control peptide targeting the corresponding region of the L-type Ca 2+ channel (Ca V 1.1) had little effect (<15%; Figures 6D and 6E ). Third, unlike WT Ca V 2.2, OE of 
ATP Is Released by CiVDS
Although the presence and kinetics of activity-dependent Cm signals of CiVDS have been well-studied in DRG neurons (Liu et al., 2011; Yang et al., 2005; Zhang et al., 2004; Zhang and Zhou, 2002; Zheng et al., 2009) , it is important to determine the cargo content of CiVDS vesicles. It is known that ATP is released via CDS in DRG somata (Zhang et al., 2007a) . To identify the CiVDS cargo, we used luciferase-luciferin assays to specifically measure possible ATP release during CiVDS and CDS. Dipyridamole (10 mM), an ATPase inhibitor, was used to reduce the hydrolysis of ATP. We found that, , 1980) , 0Ca caffeine (20 mM), instead of 2Ca 100K solution, was used to trigger CDS (Chen et al., 2005) . Under these conditions, we detected a robust ATP signal ( Figures 7A and 7B ). The evoked ATP release was from intact neurons because lactate dehydrogenase (LDH), a marker of cell injury, was detected only after applying digitonin ( Figures 7A and 7B ). Collectively, these findings demonstrate that ATP is released via both CiVDS and CDS in freshly isolated DRG neurons. Next we aimed to visualize CiVDS-mediated exocytosis at the single-vesicle level with electron microscopy (EM) and total internal reflection fluorescence (TIRF) microscopy (Wang et al., 2016; Zenisek et al., 2000) . First, with EM, we found that docked vesicles ($100 nm in diameter) were notably reduced after 2 min incubation in 0Ca 100K solution, implying that ATP can be released from these CiVDS-like vesicles (both clear and dense-core vesicles; Figures 7C and 7D ). Second, with TIRF imaging, synaptophysin (Spy)-pHluorin was expressed in DRG neurons cultured for $24 h to image the exocytosis of SpypHluorin-labeled individual vesicles in real time (Zhu et al., 2009 7F ; Movies S1 and S2), implying that ATP can be released from CiVDS-mediated Spy-pHluorin-labeled clear vesicles. Third, again with TIRF, neuropeptide Y (NPY)-pHluorin was expressed in DRG neurons cultured for $24 h to image the quantal release of NPY-pHluorinlabeled vesicles in real time (Perrais et al., 2004) . Following depolarization, NPY-pHluorin was discharged from single vesicles in DRG neurons bathed in both Ca 2+ -free and Ca 2+ -containing solution (Figures 7G and 7H ; Movies S3 and S4), implying that ATP can be released from CiVDS-mediated dense-core vesicles. In addition, the release of both Spy-pHluorin-and NPY-pHluorinlabeled vesicles under CiVDS conditions was inhibited by a Ca V 2.2 blocker (GVIA; Figures 7F and 7H) , further strengthening the role of Ca V 2.2 channels in CiVDS.
DISCUSSION
In the present work, we demonstrated that the molecular machinery of CiVDS contains a voltage sensor, a fusion pore, and a linker. Cav2.2 functions as the voltage sensor, the SNARE complex (SNAP25-syntaxin-VAMP2) functions as the fusion pore, and their linker is the synprint site (amino acids 772-856) within the II-III intracellular loop of Cav2.2. The signal pathway is AP / Cav2.2 / synprint / SNARE/SNAP25 / CiVDS (Figure 8 ). In addition, our results identified that ATP is a cargo of CiVDS.
One major finding of the present work is that Cav2.2 (the voltage sensor), SNARE (the fusion pore), and synprint (the linker) are the molecular building blocks of CiVDS. This is supported by the following evidence:(1) using Cm recording, TIRF imaging, and luciferase fluorescence assays, we found that the specific Cav2.2 blocker u-conotoxin GVIA inhibited CiVDS ( Figures 1A and 1B and 7A , 7B, 7F, and 7H); (2) CiVDS was rescued by OE of Cav2.2 following its spontaneous loss in cul- (1)- (11) establish the molecular building blocks of CiVDS. Our second important finding was that ATP is a released cargo of CiVDS vesicles. This conclusion is based on the following evidence: following CiVDS-like stimulation, (1) the luciferase-luciferin assay showed depolarization-triggered and Cav2.2-dependent ATP release through CiVDS ( Figures 7A and 7B) ; (2) EM imaging showed reduced numbers of docked vesicles ($100 nm) along the plasma membrane under CiVDS conditions ( Figures 7C and 7D) ; and (3) TIRF imaging showed exocytosis of Spy/NPY-pHluorin-labeled vesicles (Figures 7E-7H ; Figure S9 ; Movies S1, S2, S3, and S4). Findings (2) and (3) implied that ATP is released via exocytosis. In contrast to CDS, which occurs during burst firing (>20 Hz) corresponding to pain sensation (Zhang et al., 2007a; Zheng et al., 2009) , CiVDS is dominant during tonic firing (<4 Hz) under resting conditions (Zheng et al., 2009) , implying that CiVDS-mediated ATP release may play a role in maintaining proprioception at rest. In addition to DRG neurons, CiVDS also exists in both freshly isolated neurons and slice neurons from the trigeminal ganglion (data not shown). Future studies are needed to determine the specific role of CiVDS in sensation and whether it occurs in other cells.
CiVDS has been studied mainly with Cm recordings since 2002. Although the Cm assay provides high sensitivity and temporal resolution, it offers no information about vesicle cargos. Particularly, Cm cannot detect exocytosis in neuronal processes. These two limitations were overcome in the present study. First, by using luciferin fluorescence, we discovered that both CiVDS and CDS release ATP ( Figures 7A and 7B) , a neurotransmitter with a large number of purinergic receptors on the plasma membrane, including 2 families of P2X1-7 ionic receptors (North, 2002) and P2Y1-14 metabolic G protein-coupled receptors (GPCRs) (Abbracchio et al., 2006) . Second, by using TIRF imaging, we visualized quantal release of CiVDS from both somata and axons ( Figures 7E-7H ). Despite these advances, important open questions remain. Felmy et al. (2003) found no CiVDS contributing to excitatory postsynaptic currents (EPSCs) in synaptic transmission, consistent with our finding of the absence of CiVDS affecting EPSCs in the DRG spinal cord (Zheng et al., 2009 ). Thus, although modulatory transmitters (ATP and neuropeptides; Figures 7A and 7B; Zhang and Zhou, 2002) are released by CiVDS, it might not mediate EPSCs. However, the possibility of synaptic release of modulatory transmitters via CiVDS cannot be excluded. For example, Mochida et al. (1998) found Ca 2+ -independent enhancement of hyperosmosis-induced EPSCs by neuronal activity.
Binding and interactions occur between SNARE and voltagegated ion channels, including Ca 2+ channels (Sheng et al., 1994; Wiser et al., 1996) and K + channels (Fili et al., 2001 ). The present work establishes Cav2.2 as an essential voltage sensor in gating CiVDS. However, because interference with Cav2.2 by GVIA or RNAi did not fully abolish CiVDS (Figures 1 and 2) , we could not exclude the involvement of other voltage sensors in the remaining CiVDS in DRG neurons. Interestingly, following the idea of a non-channel function of CiVDS gated by a putative S1-S4 domain, Murata et al. (2005) discovered a novel voltage-gated phosphatase that uses the conserved S1-S4 as a voltage sensor. In addition to the voltage sensor of the S1-S4 domain, binding and interactions occur between SNARE and GPCRs in that depolarization modulates GPCR function via a putative voltage-sensing domain within the receptor (BarchadAvitzur et al., 2016; Parnas and Parnas, 2010) .
The present work establishes the Cav2.2-to-SNARE ''voltagegating fusion pore'' as a novel pathway co-existing with the canonical ''Ca 2+ -gating fusion pore'' pathway for neurotransmitter release following physiological APs in primary sensory neurons. Thus, in addition to functioning as a Ca 2+ -influx channel, Cav2.2 also acts as a novel voltage-mechanical transducer to gate the fusion pore for neurotransmitter release.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Dr. Zhuan Zhou (zzhou@ pku.edu.cn)
EXPERIMENTAL MODEL AND SUBJECT DETAILS
The use and care of animals were approved and directed by the Animal Care and Use Committee of Peking University. Adult Wistar rats (male, $60 g) were used for isolation of dorsal root ganglion neurons. Rats were housed under a 12 h light-dark cycle with food and water.
METHOD DETAILS Plasmids
Plasmids used in this work were from the following sources: the full-length rat a1B subunit (Ca V 2.2, NM_147141) was subcloned into pcDNA3/V5; Flag-Ca V 2.2 was generated by ligating the whole coding sequence of Ca V 2.2 into pCMV-Flag for immunoprecipitation experiments; full-length rabbit a1C (Ca V 1.2, NM_012517) and rat a1H (Ca V 3.2, NM_153814) were from Prof. W. A. Catteral (University of Washington) and D. Atlas (Hebrew University of Jerusalem); full-length SNAP-25 (NM_001270575), tetanus toxin, and botulinum toxin C-type plasmids were from Prof. L. Chen (Peking University, Beijing); and CACNB3 and CACNA2D1 were from Addgene (USA). The nucleotide target sequences GG ACA TTT CTG CAA GCC TTA A (shCa V 2.2-1) and GC TAC TTC CGG TCT TCC TTC A (shCa V 2.2-2) were integrated into adeno-associated virus to silence the expression of Ca V 2.2. A random sequence (TTC TCC GAA CGT GTC ACG T) that was predicted to target no genes in human, rat, and mouse cells was chosen as a negative control (Guangzhou RiboBio). For S4 mutation of Ca V 2.2, the amino-acids at 1256 and 1259 in the S4 segment of domain III were changed from R to Q. For pore-region mutation of Ca V 2.2, the amino-acids at 314 and 664 were changed from E to Q. For synprint truncation of Ca V 2.2, amino-acids 772 to 856 were deleted. All mutations were produced by PCR using the QuikChange site-directed mutagenesis kit (Stratagene). All constructs were verified by DNA sequencing.
Antibodies
The primary antibodies used for western blotting and immunofluorescence (IF) studies were anti-actin (A5316, Sigma), anti-Ca V 2.2 (ACC-002 from Alomone Labs, 152313 and 152311 from Synaptic Systems), anti-SNAP-25 (111011 and 111002, Synaptic Systems), and anti-flag (F1804, Sigma). The highly cross-adsorbed secondary antibodies for IF staining were all from Invitrogen. They were Alexa FluorÒ 488 goat anti-mouse IgG (H+L) (A11029), Alexa FluorÒ 594 goat anti-mouse IgG (H+L) (A11032), Alexa FluorÒ 488 goat anti-rabbit IgG (H+L) (A11034), and Alexa FluorÒ 594 goat anti-rabbit IgG (H+L) (A11037). The secondary antibodies for western blotting were IRDye 800CW goat anti-rabbit IgG (LIC-926-32211, LI-COR Biosciences) and IRDye 680CW goat anti-mouse IgG (LIC-926-32220, LI-COR Biosciences).
Cell Culture and Transfection
The use and care of animals was approved and directed by the Animal Care and Use Committee of Peking University. Isolation of dorsal root ganglion (DRG) neurons was performed as previously described (Wang et al., 2016; Zhang et al., 2004; Zhang and Zhou, 2002) . Briefly, DRGs were isolated from adult Wistar rats (male, $60 g) and placed in ice-cold L15 medium (GIBCO). The ganglia were dissected and then treated with trypsin (0.2-0.3 mg/ml) and collagenase (1 mg/ml) for 40 min at 37 C. Cells were collected and transfected with the Neon 100 mL transfection system (MPK10096, Invitrogen). Cells were then plated on poly-Llysine-coated coverslips and maintained in DMEM-F12 (GIBCO) supplemented with 10% FBS (GIBCO). After transfection for 24 h, the medium was replaced by Neurobasal-A (GIBCO) supplemented with 2% B27 (GIBCO), 0.5 mM L-glutamine (GIBCO), 10 ng/ml nerve growth factor, and 5 mM cytosine arabinoside. Experiments were performed during 1-8 h for acute use, and 1-3 days in vitro (DIV) for OE. For KD efficiency, shRNA-carrying and control adeno-associated viruses 2/5 (Shanghai He Yuan Biotech) were used to infect DRG neurons at DIV1, and western blotting was performed at DIV7-8. HEK293A cells were cultured in DMEM supplemented with 10% FBS. For transfection, plasmids were delivered using VigoFect (Vigorous Biotechnology Beijing). Immunoprecipitation and blotting analyses were performed 2-3 days after transfection.
Adeno-Associated Virus In Vivo Injection
For in vivo injection, male Sprague-Dawley rats (250-300 g) were placed in a transparent plastic box and anaesthetized with a mixture of 4% isoflurane in O 2 /N 2 O (30:70 v/v) until the animal was completely anaesthetized ($2 min). Then, each rat was fixed in a stereotaxic frame (RWD Life Science), an incision was made along the midline of the back, and the left paravertebral region was exposed. The left paraspinal muscles were separated from the transverse process at the L5 level, and connective tissue and muscles were removed using iridectomy scissors until the left L5 intervertebral foramen could be identified. The L5 nerve and DRG were exposed using bone micro-rongeurs. A 33-gauge needle with a slightly bent beveled tip was then advanced 2-4 mm into the foramen. The DRG injection was performed at $60 relative to the spine and 100 nL/min was injected for 10 min to avoid leakage into adjacent tissues. The needle was allowed to remain in place for another 20 min after injection, and then slowly withdrawn. Afterward, the incision was sutured and animals were placed on a 37 C plate for recovery.
Gel Electrophoresis and Western Blotting
Cells were washed with phosphate balanced saline (PBS) and homogenized on ice with lysate buffer [20 mM HEPES at pH 7.4, 100 mM KCl, 2 mM EDTA, 1% NP-40, 1 mM PMSF, and 2% proteinase inhibitor (539134, Calbiochem)]. The homogenates were centrifuged at 16000 g for 15 min at 4 C and the supernatants were collected and boiled in SDS-PAGE buffer. Proteins were electrophoresed and transferred to nitrocellulose filter membranes. The membranes were blocked for 1 h by PBS containing 0.1% and 5% non-fat dried milk (w/v). After washing with 0.1% Tween-20 containing PBS (PBST), the blots were incubated with primary antibodies at 4 C overnight in PBST containing 2% bovine serum albumin (BSA). Secondary antibodies were then applied at room temperature for 1 h. Blots were scanned with an Odyssey infrared imaging system (LI-COR Biosciences) and quantified with ImageJ (National Institutes of Health, Bethesda, MD).
Co-immunoprecipitation
Protein lysates from DRGs of all levels or HEK293A cells transfected with the indicated plasmids were collected in the lysate buffer described above, followed by centrifugation at 16000 g for 15 min. The supernatant was pre-cleaned with Protein G/A Sepharose 4 Fast Flow (17-6002-35, GE Life Sciences) for 1 h at 4 C, and incubated with the indicated antibodies and Protein G/A agarose beads for 8-12 h at 4 C. After that, the beads were washed three times with lysate buffer and protein was eluted by adding sample loading buffer and heating to 100 C for 6 min. The samples were then electrophoresed and transferred to nitrocellulose filter membranes for western blot analysis.
Cell Surface Biotinylation Assay HEK293A cells expressing the indicated plasmids were biotinylated with 500 mg/ml EZ-link sulfo-NHS-SS-biotin (Pierce) in PBS for 1 h at 4 C. After quenching with PBS containing 100 mM glycine, the cells were lysed in RIPA buffer (25 mM Tris, pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1% Triton X-100, 0.1% SDS, and proteinase inhibitor mixture), followed by centrifugation at 16000 g for 15 min. Then the supernatants were collected and incubated with Ultralink Plus immobilized streptavidin beads (Pierce) for 8-12 h at 4 C. After washing three times with RIPA buffer, proteins were eluted by adding sample loading buffer and boiling for 6 min. The samples were then electrophoresed and transferred to nitrocellulose filter membranes for western blot analysis.
Immunofluorescence Cells were washed 3 times with PBS and then fixed in 4% paraformaldehyde for 30 min. After that, the cells were treated with 0.3% Triton X-100 in PBS containing 2% BSA for 5 min at room temperature. After blocking for 1 h with 2% BSA in PBS, cells were incubated with primary antibodies for 1 h at room temperature. The cells were washed three times with blocking solution, and then incubated for 1 h with secondary antibodies. After washing three times in blocking solution and once in PBS, cells were plated on slides with 50% glycerol. Images were captured on an LSM 710 inverted confocal microscope (Carl Zeiss), and then processed with MBF ImageJ software (National Institutes of Health, USA) and Adobe Photoshop (Adobe Systems). Co-localization analysis was performed using ZEN 2010 (Carl Zeiss) with default M1 and M2 coefficients.
Electrophysiology
Membrane capacitance (Cm) and current were measured under the whole-cell configuration using an EPC10/2 amplifier controlled by Pulse software (HEKA Elektronik) as described previously (Zhang and Zhou, 2002) . The membrane potential was clamped at À70 mV, and pipette resistance was controlled between 2.5 and 3.5 MU. The standard external solution (SE) contained (in mM) 150 NaCl, 5 KCl, 2.5 CaCl 2 , 1 MgCl 2 , 10 H-HEPES, and 10 D-glucose, pH 7.4. The Ca 2+ -free SE for CiVDS recording was the same as SE, except that 2.5 mM Ca 2+ was replaced by 1 mM EGTA. In 10 mM Ca 2+ or 100 mM K + external solution, the concentration of NaCl was reduced to maintain the same ionic strength. The standard intracellular pipette solution (SI) contained (in mM) 153 CsCl, 1 MgCl 2 , 10 H-HEPES, and 4 Mg-ATP, pH 7.2. The synprint and control peptides (both at 2 mM; Shanghai ChinaPeptides) were diluted into the intracellular solution to assess the effect of synprint on secretion. All recordings were performed at room temperature (25 C).
Igor software (Wavemetrics, Lake Oswego, OR) was used for all offline data analysis, and series conductance and membrane conductance were used to monitor the seal condition of patch-clamp recordings.
Ca 2+ Imaging Cytosolic Ca 2+ was measured with the indicator Fura-2 AM (Invitrogen) as previously described (Zhang and Zhou, 2002) . Briefly, DRG neurons were loaded with 5 mM Fura-2 AM for 10 min at 37 C and then washed 3 times with normal external solution at room temperature. [Ca 2+ ] i was measured by epifluorescence imaging using an Olympus IX-70 inverted microscope equipped with a monochromator-based system (TILL Photonics, Planegg, Germany). X-chart software (HEKA Elektronik) was used to collect imaging data. [Ca 2+ ] i was calculated from the ratio (R) of the fluorescent signals excited at 340 nm and 380 nm with the following equation: ½Ca 2 + i = K d 3ðR À R min Þ=ðR max À RÞ, where K d , R min , and R max are constants obtained from in vitro calibration.
Electron Microscopy
Electron microscopy was performed as previously described (Wang et al., 2016) . Acutely isolated DRG neurons were washed 3 times with normal Ca 2+ -containing solution and then incubated in Ca 2+ -free or 100 mM K + external solution for 2 min. Cells were then fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in PBS for at least 30 min at room temperature. Cells were then post-fixed for 30 min with 1% osmium tetroxide, washed, dehydrated through an ethanol series, embedded in Epon, and polymerized at 60 C for 36 h. The embedded samples were separated from the dishes by dipping in liquid nitrogen and hot water. Cells of interest were isolated and mounted on pre-polymerized Epon blocks. Ultra-thin sections ($80 nm) were cut parallel to the cell monolayer, collected on single-slot, formvar-coated copper grids, and stained with 2% uranyl acetate for 30 min and 0.5% lead citrate for 15 min. Samples were observed in a Tecnai G2 20 200 KV transmission electron microscope at 120 kV. Docked vesicles were identified as those without any measurable distance (< 5 nm) from the plasma membrane.
TIRF Imaging
TIRF imaging was performed on an inverted microscope with a 100 3 TIRF objective lens (Olympus IX-81; numerical aperture 1.45). Images were captured by an Andor EMCCD using Andor iQ software with an exposure time of 50 ms. The temperature was kept at $35 C by a laboratory-made heater throughout all TIRF experiments. Electrical field stimulation was applied using an electronic stimulator (Nihon Kohden, SEN-3201). To distinguish between fusion events and vesicle movement, exocytotic events were defined as abrupt fluorescence increases at the center of pHluorin puncta immediately followed by a decrease (Spy-pHluorin) or diffusion (NPY-pHluorin) of puncta in the vicinity to baseline or even lower levels (Matsuda et al., 2009; Xia et al., 2009) . Fluorescence intensity values were calculated and analyzed using ImageJ.
Extracellular ATP Measurements
The concentration of extracellular ATP was quantified with a bioluminescence method using the luciferase-luciferin assay modified from Zhijun Zhang et al. (Zhang et al., 2007b) . After washing 3 times in normal external solution, the acutely isolated DRG neurons were incubated in Ca 2+ -free solution for 5 min and then the supernatant was collected. After that, 0Ca 100K or 0Ca caffeine (20 mM) was applied to the DRG neurons for 5 min and the supernatant was collected. The ectonucleotidase inhibitor dipyridamole (10 mM) was in the extracellular solution throughout the experiment to decrease ATP hydrolysis. A 50 mL sample was added to 100 mL of ATP assay mix containing luciferase-luciferin buffer. Luminescence was measured with a Synergy-HTX multi-mode reader (Gene). A calibration curve was obtained from standard ATP samples and the recording solution was measured as the background.
QUANTIFICATION AND STATISTICAL ANALYSIS Statistical Analysis
All experiments were performed with controls side-by-side and in random order, and were replicated at least three times. Sample sizes are consistent with those reported in similar studies. Data are shown as mean ± s.e.m. Statistical comparisons were performed with the two-tailed Student's t test, one-way ANOVA, or two-way ANOVA as indicated. The distribution of the variables in each experimental group was approximately normal. All tests were conducted using Statistical Package for the Social Sciences version 20.0. Significant differences were accepted at p < 0.05.
